[#item_full_content] MediPharm Labs has commercially launched a full-spectrum CBD oral oil in Brazil through its partner Alko do Brasil, following ANVISA authorization. The product is manufactured at MediPharm’s GMP-certified facility in Canada and meets Brazil’s strict regulatory standards. This launch marks a significant step in MediPharm’s international growth strategy, tapping into Brazil’s fast-growing medical cannabis market, estimated at C$2.58 billion. The product is now available by prescription in Brazilian pharmacies, supporting patient access to regulated cannabinoid therapies. Read More